BC
BIO icon

Burney Company’s Bio-Rad Laboratories Class A BIO Stock Holding History

Burney Company’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-330
Closed -$249K – 572
2021
Q4 		$249K Buy
330
+5
+2% +$3.74K 0.01% 534
2021
Q3 		$242K Sell
325
-13
-4% -$9.74K 0.01% 524
2021
Q2 		$218K Buy
+338
New +$206K 0.01% 559
2020
Q2 		– Sell
-1,410
Closed -$494K – 485
2020
Q1 		$494K Sell
1,410
-10
-0.7% -$3.68K 0.04% 301
2019
Q4 		$525K Buy
1,420
+28
+2% +$9.87K 0.03% 330
2019
Q3 		$463K Sell
1,392
-185
-12% -$60.4K 0.03% 325
2019
Q2 		$493K Buy
+1,577
New +$472K 0.03% 324

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return